コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 tially enhance our understanding of CD4(+) T cell recognition.
2 , without altering peptide conformation or T cell recognition.
3 ized neighboring melanoma cells for CD4(+) T cell recognition.
4 act as a signal for the host to activate NK-cell recognition.
5 ts MHC class II molecules to impair CD4(+) T cell recognition.
6 during infection resulting in a defect in T cell recognition.
7 mited repertoire of antigenic peptides for T-cell recognition.
8 an allograft that does not prompt innate NK cell recognition.
9 ional protection against CD8(+) and CD4(+) T cell recognition.
10 ndin type 1 repeats, implying a role in host cell recognition.
11 Ag-dependent manner, thereby modulating MAIT cell recognition.
12 lated viral peptides, resulting in altered T cell recognition.
13 ion of tumor cells to human Vgamma9Vdelta2-T cell recognition.
14 epitope where this modification abolished T cell recognition.
15 that the latter is involved with p23 in host cell recognition.
16 ricted manner, and peptide is required for T cell recognition.
17 ent in HERV transcription without altering T cell recognition.
18 uences of such force-induced unbinding for T cell recognition.
19 d or select for mutant viruses that escape T cell recognition.
20 T cell receptor ligand CD1d, abrogating iNKT cell recognition.
21 esting a potential CMV evasion to KIR2DL3 NK cell recognition.
22 ting fundamental differences in gammadelta T cell recognition.
23 CD8, which functions as coreceptor for tumor-cell recognition.
24 les to the immunological synapse upon target cell recognition.
25 esentation as a critical factor for CD4(+) T-cell recognition.
26 ant role in inflammation, immunity, and self-cell recognition.
27 polarized membrane structures involved in T cell recognition.
28 are directionally released following target cell recognition.
29 n, however, does not always correlate with T-cell recognition.
30 in early-stage biofilm development and host cell recognition.
31 nts a major molecular hurdle necessary for T-cell recognition.
32 that did not facilitate strong escape from T cell recognition.
33 e primarily for the peptide specificity of T-cell recognition.
34 resented peptides contribute critically to T-cell recognition.
35 Ls that select viral variants which escape T-cell recognition.
36 tial method to exogenously control events in cell recognition.
37 CTL escape, and a mutation at P8 enhanced T-cell recognition.
38 resent phosphopeptides for specific CD4(+) T cell recognition.
39 ophisticated strategies to circumvent immune cell recognition.
40 minish class I HLA binding, or (iii) alter T-cell recognition.
41 intraepitope sequence variability has upon T-cell recognition.
42 to differences in peptide presentation and T cell recognition.
43 A1 (BTN2A1) as essential to Vgamma9Vdelta2 T cell recognition.
44 periplasm of inhibitor cells prior to target-cell recognition.
45 e carrier protein were critical for helper T cell recognition.
46 pressed many receptors involved in apoptotic cell recognition.
47 FN-gamma production in the context of target cell recognition.
48 and TNF and IFNgamma production upon target-cell recognition.
49 biquitin-binding receptor NBR1, precluding T cell recognition.
50 endosomal degradation, in order to evade NK cell recognition.
51 ie many biological phenomena, including cell-cell recognition.
52 mechanism by which M. tuberculosis evades T cell recognition.
53 acent residues, abrogating TCR binding and T-cell recognition.
54 igation, with the potential to broaden ML NK cell recognition against a variety of NK cell-resistant
55 e the binding landscape for metal-specific T cell recognition, alanine screens were performed on a se
56 ddition to their appropriate genotypes, cell-cell recognition also requires compatible phenotypes, wh
58 tures on cell surfaces are critical for cell-cell recognition and adhesion and in host-pathogen inter
59 is an intricate process that is initiated by cell recognition and adhesion, and culminates in cell me
61 microneme complex, which contributes to host cell recognition and attachment via the action of TgMIC1
62 mplexes (MHC) play a critical role in immune cell recognition and can trigger an antitumor immune res
63 he generation of mutant viruses that evade T cell recognition and cannot be avoided by simply increas
65 hat tumor cell PIK3CA-AKT signaling limits T cell recognition and clearance of pancreatic cancer cell
67 ncreasingly recognized as important to tumor cell recognition and destruction, as well as to protecti
68 nd computational methods for understanding T cell recognition and discuss the potential for improved
70 s often have extended fibers to mediate host cell recognition and entry, serving as promising targets
73 assembly has shown high potential for cancer cell recognition and for in vivo drug delivery applicati
74 In this study, we have characterized the T cell recognition and immune responses in mice to two nat
76 ycoprotein spike complex (GPC) mediates host cell recognition and is an important determinant of cros
82 ivity of WGA-Fc effectively modulates fungal cell recognition and promotes the elimination of fungal
83 P6 facilitate influenza virus escape from T-cell recognition and provide a model for the number, nat
84 uces ligand density on tumor cells for CAR T-cell recognition and releases a soluble BCMA (sBCMA) fra
85 Our results show that ancient mechanisms of cell recognition and selection are active in humans and
86 SI is an important model system for cell-to-cell recognition and signaling and could be potentially
88 derlying immunity to pathogens that resist T cell recognition and the extracellular cues governing pl
89 ould control the orientation of the particle-cell recognition and thereby the initiation of T cell ac
90 een learnt about the mechanisms of apoptotic cell recognition and uptake, several key areas remain in
92 cellular functions, e.g. tumor and apoptotic cell recognition and wound healing, but the mechanism of
94 ciated with host receptors required for host cell recognition, and calcineurin function distinguishes
95 more neo-antigens, increasing chances for T cell recognition, and clinically correlates with better
97 ecause the target epitopes for CD4 and CD8 T-cell recognition are "unlinked" on different cells (reci
98 phasize the merits of including functional T cell recognition assays to gain a more complete picture
99 sed individuals, suggesting cross-reactive T cell recognition between circulating "common cold" coron
100 ved cell adhesion proteins are implicated in cell recognition between synaptic partners, but how thes
102 lls in a manner that may decrease HLA- tumor cell recognition but allows for improved NK cell-mediate
103 only implicates the citrulline residue in T cell recognition but also highlights the potential value
104 y rendering them less vulnerable to CD8(+) T-cell recognition but at increased risk of NKG2A(+) NK ce
105 ith its hydrophilic head group exposed for T-cell recognition, but CD1b structures show scaffold lipi
107 Tumor cells frequently escape from CD8+ T cell recognition by abrogating MHC-I antigen presentatio
108 gets of the bacillus, as defined by strong T-cell recognition by both mice and humans infected with M
109 roautophagy targeting could improve melanoma cell recognition by CD4(+) T cells and should be explore
111 of abundant peptide presentation for target cell recognition by immunodominant CTL was tested by sma
113 irment was not related to a defect in target cell recognition by NK cells but to the degradation of N
115 late in the lytic cycle and impairs CD8(+) T cell recognition by targeting cell surface MHC class I m
116 al (cis) associations and regulation of cell-cell recognition by trans interaction with ganglioside b
117 R1-Ag tetramers that specifically stain MAIT cells, recognition by the MAIT TCR, and our emerging und
119 processes, including non-self-cell and self-cell recognition, cell signaling, cellular structure mai
120 position 5 (P5) within the epitope reduced T-cell recognition, changes at P4 or P6 enabled CTL escape
121 ered a diverse library of multireceptor cell-cell recognition circuits by using synthetic Notch recep
122 spective on investigating human gammadelta T-cell recognition, demonstrating that diversification at
124 e evasion can involve abrogation of leukemia cell recognition due to loss of HLA genes, immunosuppres
129 l processes, from protein quality control to cell recognition, energy storage, and cell wall formatio
132 atment, HCMV evasins cooperatively impared T cell recognition for several different MHC I allotypes.
134 llotypes, single evasins largely abolished T cell recognition; for others, a concerted action of evas
135 ting that translocation accelerated infected cell recognition from after to before HLA-I downregulati
136 The results provide new insights into the cell recognition function of Pcdh-gammaC4 in neurons and
144 tion profiling for the characterization of T-cell recognition in various diseases, including in small
145 ) has evolved elaborate ways to evade immune cell recognition, including downregulation of classical
146 in understanding the molecular basis of cell-cell recognition, including unique phenomena associated
147 ells, modulation of Akt was linked to target cell recognition, independently of phagocytosis, whereas
152 genic for the H-2 locus indicates that CD4 T-cell recognition is necessary for autoantibody productio
153 n atlas-guided voxel classification process: cell recognition is realized by smoothly deforming the a
156 sponses, which limits the diversity of CD4 T cell recognition, is generally attributed to intracellul
159 le from dead cells, the phage selectivity in cell recognition minimizes false-negative and false-posi
160 ate that four adhesion molecules of the Irre cell recognition module (IRM) family play a redundant ro
161 potentially encodes 19,008 ectodomains of a cell recognition molecule of the immunoglobulin (Ig) sup
162 suggest Kirrel3 functions as a synaptogenic, cell-recognition molecule, and this function is attenuat
165 by cell-type-specific programs with diverse cell recognition molecules expressed in different combin
167 f-avoidance is mediated by a large family of cell recognition molecules of the immunoglobulin superfa
168 sophila Dscam1 gene encodes a vast number of cell recognition molecules through alternative splicing.
170 of this interaction than those of other cell-cell recognition molecules will require CD4 mutants with
174 imeric antigen receptors (CARs) direct tumor cell recognition of adoptively transferred T cells.
176 omyces dermatitidis confers protection via T cell recognition of an unknown but conserved antigen.
177 Here we review recent advances in CD8(+) T cell recognition of antigen in lymphoid as well as in no
180 timulatory endogenous peptides can enhance T cell recognition of antigen, but MHCI- and MHCII-restric
184 ass the therapeutic requirement for CD8(+) T cell recognition of cancer cells and may provide a gener
185 usly unknown skin immune response based on T cell recognition of CD1a proteins and lipid neoantigen g
187 trate the need to evaluate MHC binding and T cell recognition of Cys-containing peptides under condit
189 findings help to clarify the mechanism of T-cell recognition of gp100 during melanoma responses and
190 designed to enhance MHC binding and hence T cell recognition of gp100 in HLA-DR4(+) melanoma patient
192 R-TCR gene therapy, we analyzed transgenic T-cell recognition of hematopoietic stem cells (HSCs) and
195 e process of membrane fusion, and blocking T-cell recognition of HLA class II-peptide complexes throu
197 ted, there was a specific defect in CD8(+) T cell recognition of HLA-E/Hsp60sp, which was associated
200 mouse model that HLA-DRB1*04:02-restricted T cell recognition of human Dsg3 epitopes leads to the ind
201 ntly understood to focus on deflecting CD8 T cell recognition of infected cells by disrupting antigen
204 er, intravital imaging suggests that early B-cell recognition of large foreign antigens may be transi
205 efficiently cross-presented whereas direct T cell recognition of leukemia cells intensifies exhaustio
217 t- versus-host disease (GVHD) due to human T-cell recognition of murine major histocompatibility comp
218 In this study, we investigate the basis of T cell recognition of myelin that governs the progression
221 ctivity has been correlated with activated T-cell recognition of neoantigens, which are tumour-specif
223 Our findings suggest that efficient CD4(+) T-cell recognition of neurotropic JCV variants is crucial
224 rmationally flexible, potentially reducing B-cell recognition of neutralizing antibody epitopes.
225 e immune responses have been attributed to T-cell recognition of peptides derived from the coupled ca
227 compatibility complex class II binding and T-cell recognition of polymorphic sequences were evaluated
232 that reveal barriers preventing peripheral T cell recognition of self-peptide-MHC complexes, as well
236 gated alloantibody produced through naive Th cell recognition of target alloantigen but, crucially, b
238 chanisms play a crucial role in subsequent T-cell recognition of target cells and the specificity of
239 that fetal intervention enhances maternal T cell recognition of the fetus and that T cell activation
240 rocess also may lead to increased maternal T cell recognition of the foreign conceptus and subsequent
241 5 transgenic and NOD mice, we investigated T-cell recognition of the HIP2.5 epitope, which is a fusio
244 wever, little is known about the nature of T cell recognition of the polysaccharide-MHCII complex or
245 to make protoxin expression dependent upon T-cell recognition of the prostate-specific membrane antig
246 luded by self-N-glycan shielding, limiting B cell recognition of the underlying polypeptide surface.
250 ived peptide ligands is essential for CD8+ T-cell recognition of Toxoplasma gondii infected cells.
252 EphA2 monoclonal antibodies are coapplied, T-cell recognition of tumor cells is further increased ove
253 bone marrow of MM patients to inhibit CAR T-cell recognition of tumor cells, and potentially limit e
256 -LPD, with failures ascribable to impaired T-cell recognition of tumor-associated viral antigens or t
257 tral tenet of cancer immunoediting is that T-cell recognition of tumour antigens drives the immunolog
258 afforded by the CLDC adjuvant required CD8 T-cell recognition of viral peptides presented by classica
261 by continual processing of graft parenchymal cells; recognition of donor haemopoietic fraction was no
262 d Ca(2+) mobilization (p = 0.016) and target cell recognition (p < 0.0001), with the latter independe
263 r role in key biological events such as cell-cell recognition, pathogenesis inflammation, and host pa
264 us and henipavirus parasitization of cell-to-cell recognition pathways for systemic virus disseminati
265 a unique example of pathogen mimicry of host-cell recognition pathways that drive virus capture and d
267 nder nonhematopoietic cells susceptible to T cell recognition, prevention of such circumstances favor
269 of RIG-I on tumor antigen presentation and T cell recognition proposes innate immunoreceptor targetin
270 esion molecule (Dscam) genes encode neuronal cell recognition proteins of the immunoglobulin superfam
271 es probably affect T-cell and natural killer cell recognition, providing a sound basis for the joint
272 educed microglial surveillance and apoptotic cell recognition receptor expression and was not directl
274 ures of ectodomain fragments comprising cell-cell recognition regions of mouse gamma-Pcdhs gammaA1, g
276 CD8+ T-cell activation, delivery, and target cell recognition should yield greater clinical benefit.
279 Synapse formation is comprised of target cell recognition, synapse assembly, and synapse maintena
280 concerning the origins and evolution of cell-cell recognition systems involved in discrimination betw
283 o viral evasion of natural killer cells or T cell recognition, the evasion of antibody-mediated effec
284 homophilic binding between cells, conferring cell recognition through a poorly understood mechanism.
285 idal invasive disease in Africa, escape MAIT cell recognition through overexpression of ribB This bac
287 c design aimed at focusing both B cell and T cell recognition to a single short glycan displayed at t
289 residues of antigenic epitopes that weaken T cell recognition to the point that the immune system is
290 rs, a resurgence in discoveries underlying T-cell recognition, tumor immune evasion, and T-cell memor
291 culin (CRT), a protein involved in apoptotic cell recognition, was found to be a new PR3 partner coex
292 lecules present phosphopeptides for CD4(+) T-cell recognition, we determined the crystal structure of
293 itutions that result in escape from CD8(+) T cell recognition were not observed, premature stop codon
294 NK cell effector capacity and during target cell recognition, where the engagement of inhibitory rec
295 hor positions often significantly enhanced T cell recognition, whereas substitutions at non-MHC ancho
296 ion program in NK cells that promotes target cell recognition while limiting cytokine-driven activati
297 has been implicated downstream of apoptotic cell recognition while Toll-like receptors are the proto
298 e cell surface in order to evade cytotoxic-T-cell recognition, while leaving HLA-C and HLA-E molecule
299 reate a simple mathematical model coupling T-cell recognition with an evolving cancer population that
300 site of HLA-DP2, played a dominant role in T cell recognition with no contribution from the HLA-DP2 a